Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina

Circulation

Volumn 98, Issue 22, 1998, Pages 2370-2376

  Liuzzo, Giovanna ^a   Buffon, Antonino ^a   Biasucci, Luigi M ^a   Gallimore, J Ruth ^b   Caligiuri, Giuseppina ^a   Vitelli, Alessandra ^c   Altamura, Sergio ^c   Ciliberto, Gennaro ^c   Rebuzzi, Antonio G ^a   Crea, Filippo ^a   Pepys, Mark B ^b   Maseri, Attilio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IRBM   (Italy)

Author keywords

Angina; Angioplasty; Interleukins; Plaque

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID PROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; INTERLEUKIN 6; NITRATE;

ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STIMULUS RESPONSE; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0032401725     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.22.2370     Document Type: Article

References (29)

1. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. Prognostic value of C-reactive protein and plasma amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
2. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore JR, Caligiuri G, Lanza GA, Quaranta G, Monaco C, Pepys MB, Maseri A. Plasma protein acute phase response in unstable angina is not induced by ischemic injury. Circulation. 1996;94:874-877.
3. Biasucci LM, Liuzzo G, Caligiuri G, van de Greef W, Quaranta G, Monaco C, Rebuzzi AG, Kluft C, Maseri A. Activation of the coagulation system doesn't elicit a detectable acute phase reaction in unstable angina. Am J Cardiol. 1996;77:85-87.
4. Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischemic heart disease. BMJ. 1996;312:1049-1050.
5. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
6. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
7. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relation of C-Reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
8. Ridker PM, Cushman M, Stamper MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
9. van Deventer SJH, Buller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood. 1990;76:2520-2526.
10. Morrone G, Ciliberto G, Oliviero S, Arcore R, Dente L, Content J, Cortese R. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem. 1988;263: 12554-12558.
11. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 1989;8:3773-3779.
12. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 1990;7:147-159.
13. Mestries JC, Kruithof EKO, Gascon MP, Herodin F, Agay D, Ythier A. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons. Eur Cytokine Netw. 1994;5: 275-281.
14. Ng SB, Tan YH, Guy GR. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J Biol Chem. 1994;269: 19021-19027.
15. Sancéau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB, and SP1 transcription factors. J Biol Chem. 1995;270: 27920-27931.
16. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994;6:87-91.
17. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani K, Tsuruya Y, Kano S. Interleukin-6 stimulates the growth of vascular cells in a PDGF-dependent manner. Am J Physiol. 1991;260:H1713-H1717.
18. van der Poll T, Levi M, Hack CE, Ten Cate U, van Deventer SJH, Erenberg AJM, de Groot ER, Jansen J, Gallati H, Buller HR, Ten Cate JW, Aarden LA. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 1994;179:1253-1259.
19. Stouthard JML, Levi M, Hack CE, Veenhof CHN, Romijn HA, Sauerwein HP, van der Poll T. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996;76:738-742.
20. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
21. Liao F, Andalibi A, de Beer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993;91:2572-2579.
22. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
23. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
24. Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ. Involvement of class II MHC molecules in the LPS induction of IL-1/TNF secretions by human monocytes: quantitative differences at the polymorphic level. J Immunol. 1989;143:913-922.
25. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine. 1992;4: 361-368.
26. Pue CA, Mortensen RF, Marsh CB, Pope HA, Wewers MD. Acute phase levels of C-reactive protein enhance IL-1β and IL-1ra production by human blood monocytes but inhibit IL-1β and IL-1ra production by alveolar macrophages. J Immunol. 1996;156:1594-1600.
27. She ZW, Wewers MD, Herzyk DJ, Sagone AL, Davis WBTI. Tumor necrosis factor primes neutrophils for hypochlorous acid production. Am J Physiol. 1989;257:L338-L345.
28. Liuzzo G, Angiolillo DJ, Ginnetti F, Caligiuri G, Rizzello V, Petrone E, Kol A, Sperti G, Biasucci LM, Maseri A. Monocytes of patients with recurrent unstable angina are hyper-responsive to LPS-challenge. J Am Coll Cardiol. 1998;March special issue:272A. Abstract.
29. Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med. 1997;336:1014-1016. Editorial.